The second, first AI developed drug enters the clinic; Aprea gets breakthrough status for myelodysplastic syndromes drug
→ Sumitomo Dainippon Pharma and the UK-based AI startup Exscientia are claiming to have brought the first AI-designed drug into the clinic. The two companies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
